BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu H, Zou L, Lu X, Sheng Y, Wang Q, Ding J, Shi L, Liu S, Xing W. Diagnostic Efficacy of Contrast‐Enhanced MRI in Detecting Residual or Recurrent Hepatocellular Carcinoma After Transarterial Chemoembolization: A Systematic Review and Meta‐analysis. J Magn Reson Imaging 2020;52:1019-28. [DOI: 10.1002/jmri.26970] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Inzerillo A, Meloni MF, Taibbi A, Bartolotta TV. Loco-regional treatment of hepatocellular carcinoma: Role of contrast-enhanced ultrasonography. World J Hepatol 2022; 14(5): 911-922 [DOI: 10.4254/wjh.v14.i5.911] [Reference Citation Analysis]
2 Turkbey B. Can BOLD fMRI Demonstrate Early Response to Chemoembolization in HCCs? Acad Radiol 2021;28 Suppl 1:S20-1. [PMID: 33958262 DOI: 10.1016/j.acra.2021.03.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]